Elevance Health (ELV) Free Cash Flow (2010 - 2026)

Elevance Health (ELV) has 17 years of Free Cash Flow data on file, last reported at $4.1 billion in Q1 2026.

• Quarterly Free Cash Flow rose 399.03% year-over-year to $4.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 billion (up 75.56% YoY) and the FY2025 annual result came in at $3.2 billion, down 30.27% from the prior year.
• Free Cash Flow climbed to $4.1 billion in Q1 2026 per ELV's latest filing, from -$209.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $6.2 billion in Q1 2023 and bottomed at -$3.3 billion in Q4 2023.
• The 5-year median for Free Cash Flow is $1.7 billion (2024), against an average of $1.5 billion.
• The widest annual swing landed in 2022, when Free Cash Flow tumbled 236.34%; it then surged 1341.13% in 2025.
• Tracing ELV's Free Cash Flow over 5 years: stood at -$1.8 billion in 2022, then slumped by 81.55% to -$3.3 billion in 2023, then jumped by 111.65% to $384.0 million in 2024, then sank by 154.43% to -$209.0 million in 2025, then surged by 2060.29% to $4.1 billion in 2026.
• Per Business Quant, the three latest ELV Free Cash Flow figures stand at $4.1 billion (Q1 2026), -$209.0 million (Q4 2025), and $775.0 million (Q3 2025).

Peer Comparison